Patent details

EP4376832 Title: OBICETRAPIB FOR USE IN TREATING OF CARDIOVASCULAR DISEASE (CVD) IN HIS HYPORESPONDERS

Basic Information

Publication number:
EP4376832
PCT Application Number:
EP2022070780
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP227544129
PCT Publication Number:
WO2023006657
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
OBICETRAPIB FOR USE IN TREATING OF CARDIOVASCULAR DISEASE (CVD) IN HIS HYPORESPONDERS
French Title of Invention:
OBICETRAPIB POUR LE TRAITEMENT DES MALADIES CARDIOVASCULAIRES CHEZ LES PATIENTS PRÉSENTANT UNE RÉPONSE INSUFFISANTE AU TRAITEMENT
German Title of Invention:
OBICETRAPIB ZUR BEHANDLUNG VON HERZ-KREISLAUF-ERKRANKUNGEN BEI HIS-HYPORESPONDERN
SPC Number:

Dates

Filing date:
25/07/2022
Grant date:
25/03/2026
EP Publication Date:
05/06/2024
PCT Publication Date:
02/02/2023
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/03/2026
EP B1 Publication Date:
25/03/2026
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
25/07/2042
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/03/2026
 
 

Name:
NewAmsterdam Pharma B.V.
Address:
Gooimeer 2-35, 1411 DC Naarden, Netherlands (NL)

Inventor

1

Name:
DAVIDSON, Michael Harvey
Address:
Netherlands (NL)

2

Name:
KASTELEIN, Johannes Jacob Pieter
Address:
Netherlands (NL)

3

Name:
DITMARSCH, Marc
Address:
Netherlands (NL)

Priority

Priority Number:
21187721
Priority Date:
26/07/2021
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 31/40; A61K 31/505; A61K 31/506; A61P 3/06;

Publication

European Patent Bulletin

1

Issue number:
202613
Publication date:
25/03/2026
Description:
Grant (B1)

2

Issue number:
202614
Publication date:
01/04/2026
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
31/07/2026
Annual Fee Number:
5
Annual Fee Amount:
52 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages